Open Government Portal
Open Data Search has recently undergone significant changes. The search page has moved to search.open.canada.ca/opendata. Please update existing bookmarks accordingly.
Found 10 records similar to Evaluation of the Coordination of Antimicrobial Resistance (AMR ) Activities
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
This report presents the findings of the evaluation of the Public Health Agency of Canada’s (PHAC) viral hepatitis and sexually transmitted infection (STI) activities.
At a Glance: Departmental Evaluation Plan for the Public Health Agency of Canada, 2021-22 to 2025-26
The Office of Audit and Evaluation (OAE) Departmental Evaluation Plan for PHAC describes the Program Evaluation Division's scheduled work for the five-year period from 2021-22 to 2025-26. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016), which requires that each department prepare a five-year plan, annually updated. The projects included in this Evaluation Plan were selected to ensure full coverage of all Grant and Contribution spending over $5 million annually over a five-year period, prior commitments in Treasury Board Submissions, the information needs of program management, and program risks, and optimal use of resources. The Departmental Results Framework (DRF), program inventory, and performance information profiles developed by PHAC have formed the basis for this plan.
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
This report presents findings from the evaluation of the Public Health Agency of Canada's (PHAC) Community Action Program for Children (CAPC) and the Canada Prenatal Nutrition Program (CPNP). The evaluation examined the CAPC and CPNP's activities from April 2015 to August 2020.
Antimicrobial resistance (AMR) continues to be one of the most significant public health threats facing the world today. Drug resistant infections threaten healthcare as we know it, as it erodes our ability to prevent and treat infections.
Briefing material prepared for the President of PHAC’s appearance at the Standing Committee on Public Accounts (PACP) of April 5, 2022
PHAC developed this Regulatory Openness and Transparency Framework (ROTF) with a view to contribute to the protection and promotion of the health of Canadians and their confidence in the regulatory system through timely and open communications on issues important to their well-being. The ROTF is consistent with the Government of Canada’s priorities related to Open GovernmentFootnote1, helps deliver on the Government’s commitments under the Cabinet Directive on Regulatory Management, and will strengthen and increase the relevance of PHAC’s regulatory policies, through engagement, transparency, and accountability.
This Plan provides an overview of the Agency’s priorities and its plans to strengthen overall population health in Canada. The report highlights PHAC’s key anticipated outcomes and results, as well as human resources and budgetary plans for the upcoming fiscal year.
This report provides an overview of PHAC’s performance and achievements over the past fiscal year in support of the Government of Canada's commitment to protect the health and safety of all Canadians, as well as its contributions to global public health efforts.